Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma (Q43645559)
Jump to navigation
Jump to search
scientific article published in June 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma |
scientific article published in June 2001 |
Statements
1 reference
Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma (English)
1 reference
Wilder RB
1 reference
Rodriguez MA
1 reference
Ha CS
1 reference
Pro B
1 reference
Hess MA
1 reference
Cabanillas F
1 reference
Cox JD
1 reference
1 June 2001
1 reference
Identifiers
1 reference